Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Change in Cash (2016 - 2025)

Historic Change in Cash for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$1.6 million.

  • Firefly Neuroscience's Change in Cash fell 28268.35% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 81839.76%. This contributed to the annual value of -$333000.0 for FY2024, which is 11597.12% down from last year.
  • Per Firefly Neuroscience's latest filing, its Change in Cash stood at -$1.6 million for Q3 2025, which was down 28268.35% from -$3.6 million recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Change in Cash high stood at $7.7 million for Q1 2025, and its period low was -$3.6 million during Q2 2025.
  • Its 5-year average for Change in Cash is $165259.0, with a median of $83641.0 in 2023.
  • Per our database at Business Quant, Firefly Neuroscience's Change in Cash tumbled by 80585.22% in 2021 and then skyrocketed by 163168.32% in 2025.
  • Over the past 5 years, Firefly Neuroscience's Change in Cash (Quarter) stood at $1.2 million in 2021, then crashed by 163.31% to -$790570.0 in 2022, then surged by 258.11% to $1.2 million in 2023, then tumbled by 53.6% to $580000.0 in 2024, then crashed by 374.66% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$3.6 million for Q2 2025, and $7.7 million during Q1 2025.